All Posts

Mar 14

XLRP

Gene Therapy Improves Functional Measures in XLRP

Jan 31

Learn About RP

A Systematic Literature Review of Disease Progression Reported in RPGR-associated X-Linked Retinitis Pigmentosa

Dec 11, 2023

AGBL5

Mutations in AGBL5 associated with Retinitis pigmentosa

Jun 9, 2023

XLRP

Overcoming the Challenges to Clinical Development of X-Linked Retinitis Pigmentosa Therapies: Proceedings of an Expert Panel

Feb 1, 2023

USH2A

USHER SYNDROME COALITION

Jul 23, 2022

Potential Treatments

Potential of endogenous regenerative technology for in situ regenerative medicine

Jun 17, 2022

Potential Treatments

A new hope for a therapy against retinitis pigmentosa

Apr 30, 2022

CLRN1

Retinal Phenotype of Patients with CLRN1-Associated Usher 3A Syndrome in French Light4Deaf Cohort

Mar 18, 2022

Potential Treatments

Antabuse may help revive vision in people with progressive blinding disorders

Mar 3, 2022

AhR

More than Meets the Eye: The Aryl Hydrocarbon Receptor is an Environmental Sensor, Physiological Regulator and a Therapeutic Target in Ocular Disease

Jan 31, 2022

Learn About RP

MalaCards: The human disease database

Jan 31, 2022

USH2A

ProQR seeking Clinical Trial Participants

Jan 26, 2022

ADIPOR1

UCI researchers discover cause, develop pharmacological treatment for reducing retinitis pigmentosa vision loss

Jan 24, 2022

RPGR

RPGR and X-linked Retinitis Pigmentosa

Jan 19, 2022

LRAT

Eluminex Biosciences Acquires Zuretinol Acetate from Retinagenix Holdings

Jan 1, 2022

Learn About RP

Retinitis Pigmentosa Pathway

Dec 21, 2021

Clinical Trial

First patients dosed in phase 2/3 gene therapy trial for retinitis pigmentosa

Sep 16, 2021

PDE6B

Coave Therapeutics and Théa Open Innovation sign exclusive agreement

Aug 16, 2021

RPE65

New Treatments for Retinitis Pigmentosa

Aug 13, 2021

ABCA4

WHAT WE HOPE TO UNDERSTAND

Gene Therapy Improves Functional Measures in XLRP

A Systematic Literature Review of Disease Progression Reported in RPGR-associated X-Linked Retinitis Pigmentosa

Mutations in AGBL5 associated with Retinitis pigmentosa

Overcoming the Challenges to Clinical Development of X-Linked Retinitis Pigmentosa Therapies: Proceedings of an Expert Panel

USHER SYNDROME COALITION

Potential of endogenous regenerative technology for in situ regenerative medicine

A new hope for a therapy against retinitis pigmentosa

Retinal Phenotype of Patients with CLRN1-Associated Usher 3A Syndrome in French Light4Deaf Cohort

Antabuse may help revive vision in people with progressive blinding disorders

More than Meets the Eye: The Aryl Hydrocarbon Receptor is an Environmental Sensor, Physiological Regulator and a Therapeutic Target in Ocular Disease

MalaCards: The human disease database

ProQR seeking Clinical Trial Participants

UCI researchers discover cause, develop pharmacological treatment for reducing retinitis pigmentosa vision loss

RPGR and X-linked Retinitis Pigmentosa

Eluminex Biosciences Acquires Zuretinol Acetate from Retinagenix Holdings

Retinitis Pigmentosa Pathway

First patients dosed in phase 2/3 gene therapy trial for retinitis pigmentosa

Coave Therapeutics and Théa Open Innovation sign exclusive agreement

New Treatments for Retinitis Pigmentosa

An Overview of the Genetics of ABCA4 Retinopathies, an Evolving Story